Nehal Rana

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Duchenne Muscular Dystrophy

Epidermal Growth Factor Receptor

Molecular Docking

Small Cell Lung Cancer

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sumera Zaib, Nehal Rana, Nadia Hussain, Hanan A Ogaly, Ayed A Dera, Imtiaz Khan
Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Molecules (Basel, Switzerland) 28 (6) (2023)
Sumera Zaib, Nehal Rana, Nadia Hussain, Hanan A Ogaly, Ayed A Dera, Imtiaz Khan
Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Molecules (Basel, Switzerland) 28 (6) (2023)
Sumera Zaib, Nehal Rana, Nadia Hussain, Hanan A Ogaly, Ayed A Dera, Imtiaz Khan
Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Molecules (Basel, Switzerland) 28 (6) (2023)
Ayed A Dera, Sumera Zaib, null Areeba, Nadia Hussain, Nehal Rana, Hira Javed, Imtiaz Khan
Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer. Molecules (Basel, Switzerland) 28 (12) (2023)
Ayed A Dera, Sumera Zaib, null Areeba, Nadia Hussain, Nehal Rana, Hira Javed, Imtiaz Khan
Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer. Molecules (Basel, Switzerland) 28 (12) (2023)
Ayed A Dera, Sumera Zaib, null Areeba, Nadia Hussain, Nehal Rana, Hira Javed, Imtiaz Khan
Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer. Molecules (Basel, Switzerland) 28 (12) (2023)